334 related articles for article (PubMed ID: 28126652)
21. PAK3 mutation in nonsyndromic X-linked mental retardation.
Allen KM; Gleeson JG; Bagrodia S; Partington MW; MacMillan JC; Cerione RA; Mulley JC; Walsh CA
Nat Genet; 1998 Sep; 20(1):25-30. PubMed ID: 9731525
[TBL] [Abstract][Full Text] [Related]
22. Alteration of synaptic network dynamics by the intellectual disability protein PAK3.
Dubos A; Combeau G; Bernardinelli Y; Barnier JV; Hartley O; Gaertner H; Boda B; Muller D
J Neurosci; 2012 Jan; 32(2):519-27. PubMed ID: 22238087
[TBL] [Abstract][Full Text] [Related]
23. The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.
Combeau G; Kreis P; Domenichini F; Amar M; Fossier P; Rousseau V; Barnier JV
J Biol Chem; 2012 Aug; 287(36):30084-96. PubMed ID: 22815483
[TBL] [Abstract][Full Text] [Related]
24. Mutations in
Woodbury-Smith M; Deneault E; Yuen RKC; Walker S; Zarrei M; Pellecchia G; Howe JL; Hoang N; Uddin M; Marshall CR; Chrysler C; Thompson A; Szatmari P; Scherer SW
Mol Autism; 2017; 8():59. PubMed ID: 29152164
[TBL] [Abstract][Full Text] [Related]
25. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
[TBL] [Abstract][Full Text] [Related]
26. Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.
Mroske C; Rasmussen K; Shinde DN; Huether R; Powis Z; Lu HM; Baxter RM; McPherson E; Tang S
BMC Med Genet; 2015 Nov; 16():102. PubMed ID: 26542245
[TBL] [Abstract][Full Text] [Related]
27. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
28. A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome.
Dunkerton S; Field M; Cho V; Bertram E; Whittle B; Groves A; Goel H
Am J Med Genet A; 2015 Sep; 167A(9):2182-7. PubMed ID: 25929198
[TBL] [Abstract][Full Text] [Related]
29. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
30. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
Rauch A; Wieczorek D; Graf E; Wieland T; Endele S; Schwarzmayr T; Albrecht B; Bartholdi D; Beygo J; Di Donato N; Dufke A; Cremer K; Hempel M; Horn D; Hoyer J; Joset P; Röpke A; Moog U; Riess A; Thiel CT; Tzschach A; Wiesener A; Wohlleber E; Zweier C; Ekici AB; Zink AM; Rump A; Meisinger C; Grallert H; Sticht H; Schenck A; Engels H; Rappold G; Schröck E; Wieacker P; Riess O; Meitinger T; Reis A; Strom TM
Lancet; 2012 Nov; 380(9854):1674-82. PubMed ID: 23020937
[TBL] [Abstract][Full Text] [Related]
31. The p21-activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42-dependent pathway.
Kreis P; Thévenot E; Rousseau V; Boda B; Muller D; Barnier JV
J Biol Chem; 2007 Jul; 282(29):21497-506. PubMed ID: 17537723
[TBL] [Abstract][Full Text] [Related]
32. A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features.
Rejeb I; Saillour Y; Castelnau L; Julien C; Bienvenu T; Taga P; Chaabouni H; Chelly J; Ben Jemaa L; Bahi-Buisson N
Eur J Hum Genet; 2008 Nov; 16(11):1358-63. PubMed ID: 18523455
[TBL] [Abstract][Full Text] [Related]
33. Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.
Reinstein E; Tzur S; Cohen R; Bormans C; Behar DM
Eur J Hum Genet; 2016 Nov; 24(11):1635-1638. PubMed ID: 27329731
[TBL] [Abstract][Full Text] [Related]
34. Novel homozygous mutation in KPTN gene causing a familial intellectual disability-macrocephaly syndrome.
Pajusalu S; Reimand T; Õunap K
Am J Med Genet A; 2015 Aug; 167A(8):1913-5. PubMed ID: 25847626
[TBL] [Abstract][Full Text] [Related]
35. De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.
Palmer EE; Stuhlmann T; Weinert S; Haan E; Van Esch H; Holvoet M; Boyle J; Leffler M; Raynaud M; Moraine C; van Bokhoven H; Kleefstra T; Kahrizi K; Najmabadi H; Ropers HH; Delgado MR; Sirsi D; Golla S; Sommer A; Pietryga MP; Chung WK; Wynn J; Rohena L; Bernardo E; Hamlin D; Faux BM; Grange DK; Manwaring L; Tolmie J; Joss S; ; Cobben JM; Duijkers FAM; Goehringer JM; Challman TD; Hennig F; Fischer U; Grimme A; Suckow V; Musante L; Nicholl J; Shaw M; Lodh SP; Niu Z; Rosenfeld JA; Stankiewicz P; Jentsch TJ; Gecz J; Field M; Kalscheuer VM
Mol Psychiatry; 2018 Feb; 23(2):222-230. PubMed ID: 27550844
[TBL] [Abstract][Full Text] [Related]
36. Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis.
Nodé-Langlois R; Muller D; Boda B
J Cell Sci; 2006 Dec; 119(Pt 23):4986-93. PubMed ID: 17105769
[TBL] [Abstract][Full Text] [Related]
37. The intellectual disability protein PAK3 regulates oligodendrocyte precursor cell differentiation.
Maglorius Renkilaraj MRL; Baudouin L; Wells CM; Doulazmi M; Wehrlé R; Cannaya V; Bachelin C; Barnier JV; Jia Z; Nait Oumesmar B; Dusart I; Bouslama-Oueghlani L
Neurobiol Dis; 2017 Feb; 98():137-148. PubMed ID: 27940202
[TBL] [Abstract][Full Text] [Related]
38. Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.
Domingues FS; König E; Schwienbacher C; Volpato CB; Picard A; Cantaloni C; Mascalzoni D; Lackner P; Heimbach A; Hoffmann P; Stanzial F; Hicks AA; Parmeggiani L; Benedicenti F; Pellegrin S; Casara G; Pramstaller PP
Seizure; 2019 Mar; 66():81-85. PubMed ID: 30818181
[TBL] [Abstract][Full Text] [Related]
39. De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease.
Ma L; Bayram Y; McLaughlin HM; Cho MT; Krokosky A; Turner CE; Lindstrom K; Bupp CP; Mayberry K; Mu W; Bodurtha J; Weinstein V; Zadeh N; Alcaraz W; Powis Z; Shao Y; Scott DA; Lewis AM; White JJ; Jhangiani SN; Gulec EY; Lalani SR; Lupski JR; Retterer K; Schnur RE; Wentzensen IM; Bale S; Chung WK
Hum Genet; 2016 Dec; 135(12):1399-1409. PubMed ID: 27681385
[TBL] [Abstract][Full Text] [Related]
40. [X-linked intellectual disability syndrome with macrocephaly due to BRWD3 gene deletion].
Arroyo-Carrera I; Romero-Peguero R; Martín-Fernández R; Ramajo-Polo A; García-Navas Núñez V
Rev Neurol; 2024 Jun; 78(11):323-326. PubMed ID: 38813790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]